- 52 次围观
产品图片

货号/SKU
NR-48812
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质,其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类:美国、3
产品描述信息
NR-48812??Human coronavirus, Middle East Respiratory Syndrome Coronavirus, Recombinant Infectious Clone with T1015N Tissue Culture Adaptation Mutation (icMERS-CoV-T1015N) (Viruses)|Human coronavirus|Middle East Respiratory Syndrome Coronavirus, Recombinant Infectious Clone with T1015N Tissue Culture Adaptation Mutation (icMERS-CoV-T1015N) |-60°C or colder|RS BaricAcknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Middle East Respiratory Syndrome Coronavirus, Recombinant Infectious Clone with T1015N Tissue Culture Adaptation Mutation (icMERS-CoV-T1015N), NR-48812."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
Recombinant infectious clone with T1015N tissue culture adaptation mutation (icMERS-CoV-T1015N).
NR-48812 is a human group 2c betacoronavirus based on the MERS-CoV, EMC/2012 genome, engineered to contain the tissue culture adaptation mutation T1015N in the S glycoprotein gene.
Each vial contains approximately 1 mL of cell lysate and supernatant from Cercopithecus aethiops kidney epithelial cells (Vero: ATCC ? CCL-81?) infected with icMERS-CoV-T1015N.
Additional information and tools are available at ViPR (Virus Pathogen Resource).
Use of this material for any purpose by commercial or for profit entities requires a license from The University of North Carolina at Chapel Hill prior to shipment. For more information on obtaining a license to use this material please contact the UNC-CH Office of Technology Development, 100 Europa Drive, Suite 430, Chapel Hill, North Carolina 27517, Phone (919) 966-3929, Email: otd@unc.edu.
Recombinant infectious clone with T1015N tissue culture adaptation mutation (icMERS-CoV-T1015N).
NR-48812 is a human group 2c betacoronavirus based on the MERS-CoV, EMC/2012 genome, engineered to contain the tissue culture adaptation mutation T1015N in the S glycoprotein gene.
Each vial contains approximately 1 mL of cell lysate and supernatant from Cercopithecus aethiops kidney epithelial cells (Vero: ATCC ? CCL-81?) infected with icMERS-CoV-T1015N.
Additional information and tools are available at ViPR (Virus Pathogen Resource).
Use of this material for any purpose by commercial or for profit entities requires a license from The University of North Carolina at Chapel Hill prior to shipment. For more information on obtaining a license to use this material please contact the UNC-CH Office of Technology Development, 100 Europa Drive, Suite 430, Chapel Hill, North Carolina 27517, Phone (919) 966-3929, Email: otd@unc.edu.
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.此限制的订单将在发货前发送到NIAID批准.
具有T1015N组织培养适应突变的重组传染性克隆(ICMER-COV-T1015N).
NR-48812是一种基于MERS-COV,EMC / 2012基因组的人组2C BetacoronaVirus,工程化
含有S糖蛋白基因中的组织培养适应突变T1015N.
每个小瓶含有大约1ml的细胞裂解物和来自 Cercopithecus Aethiops的上清液,肾上皮细胞(Vero:ATC1:ATCC ?CCL-812)感染ICMers-CoV-T1015N.
vipr (病毒病原体资源)提供了附加信息和工具.
通过商业或利润实体使用这种材料,需要在发货前北卡罗来纳大学的许可证.有关获取使用此材料的许可的更多信息,请联系UNC-CH技术开发办公室,100欧罗巴驾驶,套房430,教堂
Hill,North Carolina 27517,电话(919)966-3929,电子邮件: otd@unc.edu .
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立,旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中,可以监控科学界对这些材料的访问和使用,并确保试剂的质量控制。
除了为传染病界提供材料外,BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势,包括安全存储、社区访问和分发;同时保护存款人的知识产权。只要有需要,BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月, ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料,包括由其他政府支持的研究项目存放的材料,将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中,涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识

可能感兴趣的内容
2022-04-01
2024-01-21
2021-10-31
2019-05-08
2022-04-01
2021-12-21
2022-04-01
2022-04-01
2021-12-21
2022-06-17
2021-12-21
2024-01-21
2024-01-21
2023-11-12
2024-05-19